Skip to main content

$0.410 -0.010 (-2.38%)

High

$0.42

Low

$0.41

Trades

28

Turnover

$52,803

Volume

126,180
30 June 2023 at 3:42pm
Register to track RHY and receive email alerts.

Ethics Approval Received, New Clinical Trial Site Added

StockBot

416,823 posts

RHY released this announcement to the ASX on 27 October 2020, 8:19. The announcement is marked as price sensitive, and is 2 page(s) in length and 120.33kb in size.

You can view all announcements from RHY and see how they appear on a price chart on the announcements page.

At the date of this announcement, RHY was 0.000% short sold according to ASIC data. It was ranked the 618th most shorted stock on the ASX. It is now ranked as the 571st most shorted stock on the ASX with 0.005% of total shares short sold as of the latest reported data (13 December 2024).

Other Recent Announcements from RHY
Notification of cessation of securities - RHY 30 June 2023, 14:17
Revised Securities Trading Policy 23 June 2023, 10:28
Investor Presentation 20 June 2023, 9:21
Rhythm Continues Platform Expansion Program for Other Cancer 19 June 2023, 10:03
ColoSTAT Poster Presentation at ASCO Annual Meeting 6 June 2023, 9:46
Ethics Approval Received, New Clinical Trial Site Added 27 October 2020, 8:19
Rhythm Receives $1.1m R&D Tax Incentive 16 October 2020, 8:41
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track RHY and receive email alerts.